Pharmaceuticals
Pfizer stock rises after aligning with Trump on drug pricing
AI द्वारा रिपोर्ट किया गया
Pfizer's shares climbed on Monday after the company expressed support for former President Donald Trump's proposal to allow imports of lower-priced drugs from Canada. This stance marks a shift for the pharmaceutical giant, which has historically opposed such measures. The move comes amid ongoing debates over U.S. drug costs.
End of patent protection for weight loss injections benefits patients
Patent protection for semaglutide in weight loss injections like Ozempic and Wegovy is expiring in Europe. This paves the way for cheaper generics to enter the market and could lower high prices. Patients with obesity stand to benefit from improved access.
German pharmaceutical industry benefits from US tariff dispute
The German pharmaceutical industry sees 3.2 percent production growth amid overall economic decline. This stems from the US tariff dispute, prompting rushed exports. The Association of Research-Based Pharmaceutical Companies (VFA) anticipates sustained high turnover through year-end.
AstraZeneca Cuts Prices on Select US Drugs After Trump Pressure
AstraZeneca has announced it will offer discounts of up to 70% on certain diabetes and asthma medications sold directly to cash-paying U.S. patients, responding to demands from President Donald Trump for lower drug prices. The move aligns these prices with those paid by Medicare and marks the company as the latest in the pharmaceutical industry to adjust amid ongoing regulatory scrutiny. This development underscores the intensifying focus on drug affordability in the United States under the current administration.
Lawsuits claim Tylenol use in pregnancy causes autism
AI द्वारा रिपोर्ट किया गया
More than 100 lawsuits have been filed against acetaminophen manufacturers, including Johnson & Johnson, alleging that the drug's use during pregnancy increases the risk of autism and ADHD in children. These legal actions stem from scientific studies showing associations between prenatal exposure and neurodevelopmental disorders. The cases highlight growing concerns over the safety of a widely used pain reliever.